Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?

@article{Katona2008DoesTP,
  title={Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?},
  author={Terrence M Katona and Susan M. Perkins and Steven D Billings},
  journal={Journal of cutaneous pathology},
  year={2008},
  volume={35 2},
  pages={174-9}
}
BACKGROUND Evaluation of androgen receptor (AR) and cytokeratin 20 (CK20) expression can aid in distinguishing between conventional basal cell carcinoma (characteristically AR+, CK20-) and trichoepithelioma (frequently AR-, CK20+). Within these two groups of tumors, morpheaform/infiltrative basal cell carcinoma (mBCC) and desmoplastic trichoepithelioma (DTE) are particularly challenging to differentiate both clinically and histologically. We investigated whether AR and CK20 immunostains may… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Familial desmoplastic trichoepithelioma.

International journal of dermatology • 2006

Elevated expression of angiogenin in prostate cancer and its precursors.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2005

Merkel cells and sclerosing epithelial neoplasms

E Abesamis-Cubillan, L Shabrawi-Cailen, PE. LeBoit
Am J Dermatopathol • 2000

Similar Papers

Loading similar papers…